Search research articles
Contact Us
Filters
Showing results (251-260 of 271) with videos related to
Page
of 28
Sort By:
Cancer Discovery
|
November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2025
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database
Christian Menzer, Susanne Dugas-Breit, Martin Dugas, et al.
Nature Cancer
|
June 17, 2022
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy
Thomas Walle, Sunanjay Bajaj, Joscha A Kraske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
K C Kähler, J C Hassel, M Ziemer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma
S Piperno-Neumann, P Rutkowski, J C Hassel, et al.
Cancers
|
July 20, 2021
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2023
Treatment management for <i>BRAF</i>-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Maximilian Haist, Henner Stege, Friederike Rogall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey
Glenn Geidel, Nathan Fekade, Katharina Raabe, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study
Elizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Frontiers in Oncology
|
November 8, 2021
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis
Anne Zaremba, Rafaela Kramer, Viola De Temple, et al.
Page
of 28
Search research articles
Search
Showing results (251-260 of 271) with videos related to
Sort By:
Page
of 28
Cancer Discovery
|
November 23, 2013
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma
Eliezer M Van Allen, Nikhil Wagle, Antje Sucker, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 24, 2025
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database
Christian Menzer, Susanne Dugas-Breit, Martin Dugas, et al.
Nature Cancer
|
June 17, 2022
Cytokine release syndrome-like serum responses after COVID-19 vaccination are frequent and clinically inapparent under cancer immunotherapy
Thomas Walle, Sunanjay Bajaj, Joscha A Kraske, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 9, 2025
Neoadjuvant intralesional targeted immunocytokines (daromun) in stage III melanoma
K C Kähler, J C Hassel, M Ziemer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 20, 2026
Five-Year Survival with Tebentafusp in Metastatic Uveal Melanoma
S Piperno-Neumann, P Rutkowski, J C Hassel, et al.
Cancers
|
July 20, 2021
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis
Elias A T Koch, Anne Petzold, Anja Wessely, et al.
Journal for Immunotherapy of Cancer
|
September 20, 2023
Treatment management for <i>BRAF</i>-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG
Maximilian Haist, Henner Stege, Friederike Rogall, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 3, 2026
Translating ctDNA into cutaneous melanoma care: An international expert survey
Glenn Geidel, Nathan Fekade, Katharina Raabe, et al.
Journal for Immunotherapy of Cancer
|
March 5, 2026
Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study
Elizabeth M Gaughan, Miso Kim, Ignacio Mendez, et al.
Frontiers in Oncology
|
November 8, 2021
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition - A Descriptive Observational Retrospective Multicenter Analysis
Anne Zaremba, Rafaela Kramer, Viola De Temple, et al.
Page
of 28